company background image
CNMD logo

CONMED NYSE:CNMD 주식 보고서

최종 가격

US$72.24

시가총액

US$2.2b

7D

-1.6%

1Y

-32.9%

업데이트

15 Nov, 2024

데이터

회사 재무 +

CONMED Corporation

NYSE:CNMD 주식 보고서

시가총액: US$2.2b

CNMD 주식 개요

의료 기술 회사인 CONMED Corporation은 전 세계적으로 외과 수술용 수술 기기 및 관련 장비를 개발, 제조, 판매하는 기업입니다. 자세한 내용

CNMD 기본 분석
눈송이 점수
가치 평가5/6
미래 성장1/6
과거 실적4/6
재무 상태3/6
배당금3/6

보상

공정 가치 추정치보다 낮은 46.5% 에서 거래

수익은 매년 13.76% 증가할 것으로 예상됩니다.

지난 1년간 수익이 127.2% 증가했습니다.

동종업계 및 업계 대비 좋은 가치로 거래

위험 분석

부채는 영업현금흐름으로 충분히 감당되지 않습니다.

재무 결과에 영향을 미치는 대규모 일회성 항목


Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

WA
WarrenAI
Based on Analyst Price Targets

Innovative Leadership And Orthopedic Advances Propel Revenue And Margin Growth

Key Takeaways Succession with a focus on innovation and customer engagement could drive future revenue growth and fresh perspectives. Strong cash flow and improved balance sheet position support future investments and enhance overall earnings.
View narrative
US$83.13
FV
13.1% undervalued intrinsic discount
6.79%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
1 day ago author updated this narrative

CONMED Corporation 경쟁사

LeMaitre Vascular

NasdaqGM:LMAT

US$2.3b

NuVasive

NasdaqGS:NUVA

US$2.1b

LivaNova

NasdaqGS:LIVN

US$2.8b

InMode

NasdaqGS:INMD

US$1.6b

가격 내역 및 성능

다음에 대한 모든 사상 최고가, 변동 및 가격 하락 요약 CONMED
과거 주가
현재 주가US$72.24
52주 최고치US$117.27
52주 최저치US$61.05
베타1.46
11개월 변경10.32%
3개월 변경 사항7.24%
1년 변경 사항-32.86%
33년 변화-49.13%
5년 변화-36.23%
IPO 이후 변화3,512.00%

최근 뉴스 및 업데이트

CONMED's (NYSE:CNMD) Earnings Are Weaker Than They Seem

Nov 07
CONMED's (NYSE:CNMD) Earnings Are Weaker Than They Seem

Earnings Beat: CONMED Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Nov 02
Earnings Beat: CONMED Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Recent updates

CONMED's (NYSE:CNMD) Earnings Are Weaker Than They Seem

Nov 07
CONMED's (NYSE:CNMD) Earnings Are Weaker Than They Seem

Earnings Beat: CONMED Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Nov 02
Earnings Beat: CONMED Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Should You Investigate CONMED Corporation (NYSE:CNMD) At US$71.92?

Oct 01
Should You Investigate CONMED Corporation (NYSE:CNMD) At US$71.92?

Why We're Not Concerned About CONMED Corporation's (NYSE:CNMD) Share Price

Sep 12
Why We're Not Concerned About CONMED Corporation's (NYSE:CNMD) Share Price

CONMED (NYSE:CNMD) Is Paying Out A Dividend Of $0.20

Aug 15
CONMED (NYSE:CNMD) Is Paying Out A Dividend Of $0.20

CONMED Corporation's (NYSE:CNMD) Intrinsic Value Is Potentially 97% Above Its Share Price

Jul 17
CONMED Corporation's (NYSE:CNMD) Intrinsic Value Is Potentially 97% Above Its Share Price

AirSeal Concerns Have Let Too Much Air Out Of Conmed's Valuation

Jun 21

There Is A Reason CONMED Corporation's (NYSE:CNMD) Price Is Undemanding

Jun 01
There Is A Reason CONMED Corporation's (NYSE:CNMD) Price Is Undemanding

Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

Apr 18
Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

Is CONMED (NYSE:CNMD) Using Too Much Debt?

Mar 28
Is CONMED (NYSE:CNMD) Using Too Much Debt?

CONMED Corporation (NYSE:CNMD) Might Not Be As Mispriced As It Looks After Plunging 26%

Feb 15
CONMED Corporation (NYSE:CNMD) Might Not Be As Mispriced As It Looks After Plunging 26%

US$111: That's What Analysts Think CONMED Corporation (NYSE:CNMD) Is Worth After Its Latest Results

Feb 03
US$111: That's What Analysts Think CONMED Corporation (NYSE:CNMD) Is Worth After Its Latest Results

Should You Investigate CONMED Corporation (NYSE:CNMD) At US$107?

Jan 08
Should You Investigate CONMED Corporation (NYSE:CNMD) At US$107?

Investors Appear Satisfied With CONMED Corporation's (NYSE:CNMD) Prospects

Dec 18
Investors Appear Satisfied With CONMED Corporation's (NYSE:CNMD) Prospects

CONMED (NYSE:CNMD) Takes On Some Risk With Its Use Of Debt

Nov 30
CONMED (NYSE:CNMD) Takes On Some Risk With Its Use Of Debt

Conmed: Sector Derating And A New Competitive Threat Shouldn't Overshadow A Solid Core Business

Oct 28

Is CONMED Corporation (NYSE:CNMD) Potentially Undervalued?

Sep 22
Is CONMED Corporation (NYSE:CNMD) Potentially Undervalued?

Does CONMED (NYSE:CNMD) Have A Healthy Balance Sheet?

Aug 24
Does CONMED (NYSE:CNMD) Have A Healthy Balance Sheet?

Conmed: Reiterate Buy Rating As Earnings Are Expected To Grow Strongly

Jul 28

Should You Think About Buying CONMED Corporation (NYSE:CNMD) Now?

Jun 08
Should You Think About Buying CONMED Corporation (NYSE:CNMD) Now?

These 4 Measures Indicate That CONMED (NYSE:CNMD) Is Using Debt Extensively

May 17
These 4 Measures Indicate That CONMED (NYSE:CNMD) Is Using Debt Extensively

Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)

Apr 28
Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)

Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

Mar 10
Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

Here's Why CONMED (NYSE:CNMD) Has A Meaningful Debt Burden

Feb 14
Here's Why CONMED (NYSE:CNMD) Has A Meaningful Debt Burden

CONMED Non-GAAP EPS of $0.42 misses by $0.48, revenue of $250.9M misses by $51.58M

Feb 02

Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)

Jan 24
Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)

ConMed: Still Fairly Priced, Turning More Constructive

Dec 09

At US$83.60, Is CONMED Corporation (NYSE:CNMD) Worth Looking At Closely?

Nov 18
At US$83.60, Is CONMED Corporation (NYSE:CNMD) Worth Looking At Closely?

Conmed withdraws FY22 guidance on software implementation-related disruption

Nov 15

CONMED (NYSE:CNMD) Has A Pretty Healthy Balance Sheet

Oct 11
CONMED (NYSE:CNMD) Has A Pretty Healthy Balance Sheet

주주 수익률

CNMDUS Medical EquipmentUS 마켓
7D-1.6%-0.4%-0.5%
1Y-32.9%22.2%32.3%

수익률 대 산업: CNMD 지난 1년 동안 22.2 %를 반환한 US Medical Equipment 업계보다 저조한 성과를 냈습니다.

수익률 대 시장: CNMD 지난 1년 동안 32.3 %를 반환한 US 시장보다 저조한 성과를 냈습니다.

가격 변동성

Is CNMD's price volatile compared to industry and market?
CNMD volatility
CNMD Average Weekly Movement5.4%
Medical Equipment Industry Average Movement7.8%
Market Average Movement6.2%
10% most volatile stocks in US Market15.6%
10% least volatile stocks in US Market3.0%

안정적인 주가: CNMD 는) 지난 3개월 동안 큰 가격 변동성이 없었습니다.

시간에 따른 변동성: CNMD 의 주간 변동성( 5% )은 지난 1년 동안 안정적인 모습을 보였습니다.

회사 소개

설립직원CEO웹사이트
19704,000Curt Hartmanwww.conmed.com

의료 기술 회사인 콘메드 코퍼레이션은 전 세계적으로 수술용 의료기기 및 관련 장비를 개발, 제조, 판매하는 기업입니다. 이 회사는 정형외과 의사에게 연조직 손상의 확대 및 복구를 위한 임상 솔루션을 제공하는 BioBrace, Y-Knot 올인원 연조직 고정 시스템이 포함된 TruShot, Y-knot 올봉합 앵커, Agro Knotless 봉합 앵커 등의 정형외과 수술 제품을 제공하며, 외과의가 최소침습 스포츠 의학 수술을 수행할 수 있도록 지원하는 제품도 제공합니다. 홀(Hall), 콘메드 린바텍(Linvatec), 콘셉트(Concept), 셔트(Shutt) 브랜드로 정형외과 수술 제품을 판매합니다.

CONMED Corporation 기본 사항 요약

CONMED 의 수익과 매출은 시가총액과 어떻게 비교하나요?
CNMD 기본 통계
시가총액US$2.20b
수익(TTM)US$131.74m
수익(TTM)US$1.29b

16.9x

P/E 비율

1.7x

P/S 비율

CNMD 주가가 과대평가되어 있나요?

공정 가치 및 가치 분석 보기

수익 및 수익

최신 수익 보고서의 주요 수익성 통계(TTM)
CNMD 손익 계산서(TTM)
수익US$1.29b
수익 비용US$569.15m
총 이익US$718.96m
기타 비용US$587.22m
수익US$131.74m

최근 보고된 수익

Sep 30, 2024

다음 수익 날짜

n/a

주당 순이익(EPS)4.26
총 마진55.82%
순이익 마진10.23%
부채/자본 비율100.6%

CNMD 의 장기적인 성과는 어땠나요?

과거 실적 및 비교 보기

배당금

1.1%

현재 배당 수익률

19%

지급 비율